107 STAT. 1586 PUBLIC LAW 103-160—NOV. 30, 1993 SEC. 214. MEDICAL COUNTERMEASURES AGAINST BIOWARFARE THREATS. (a) IN GENERAL. —Chapter 139 of title 10, United States Code, is amended by inserting after section 2370 the following new section:
- § 2370a. Medical countermeasures against biowarfare
threats: allocation of funding between near-term and other threats "(a) ALLOCATION BETWEEN NEAR-TERM AND OTHER THREATS.— Of the funds appropriated or otherwise made available for any fiscal year for the medical component of the Biological Defense Research Program (BDRP) of the Department of Defense — "(1) not more than 80 percent may be obligated and expended for product development, or for research, development, test, or evaluation, of medical countermeasures against near-term validated biowarfare threat agents; and "(2) not more than 20 percent may be obligated or expended for product development, or for research, development, test, or evaluation, of medical countermeasures against mid-term or far-term validated biowarfare threat agents. "(b) DEFINITIONS.— In this section: "(1) The term Validated biowarfare threat agent' means a biological agent that— "(A) is named in the biological warfare threat list published by the Defense Intelligence Agency; and "(B) is identified as a biowarfare threat by the Deputy Chief of Staff of the Army for Intelligence in accordance with Army regulations applicable to intelligence support for the medical component of the Biological Defense Research Program. "(2) The term 'near-term validated biowarfare threat agent' means a validated biowarfare threat agent that has been, or is being, developed or produced for weaponization within 5 years, as assessed and determined by the Defense Intelligence Agency. "(3) The term *mid-term validated biowarfare threat agent' means a validated biowarfare threat agent that is an emerging biowarfare threat, is the object of research by a foreign threat country, and will be ready for weaponization in more than 5 years and less than 10 years, as assessed and determined by the Defense Intelligence Agency. "(4) The term Tar-term validated biowarfare threat agent' means a validated biowarfare threat agent that is a future biowarfare threat, is the object of research by a foreign threat country, and could be ready for weaponization in more than 10 years and less than 20 years, as assessed and determined by the Defense Intelligence Agency. "(5) The term 'weaponization' means incorporation into usable ordnance or other militarily useful means of delivery.". (b) CLERICAL AMENDMENT.— The table of sections at the beginning of such chapter is amended by inserting after the item relating to section 2370 the following new item: "23708. Medical countermeasures against biowarfare threats: allocation of funding between near-term and other threats.".
�
